Does CBD counteract THC's psychotic-like effects when used together?
A naturalistic double-blind crossover study of 18 cannabis club members found that CBD significantly reduced the psychotomimetic effects of THC when co-administered as a full-spectrum extract, while CBD alone produced no psychotic-like symptoms.
Quick Facts
What This Study Found
THC+CBD combined extracts produced significantly lower psychotomimetic scores than THC alone. CBD alone and placebo produced no psychotomimetic effects. Subjective scores under CBD and placebo were lower than under THC+CBD, confirming CBD alone was inert. The study demonstrated both THC's psychotomimetic properties and CBD's ability to attenuate them in real-world conditions.
Key Numbers
18 participants; 4 conditions (THC, CBD, THC+CBD, placebo); double-blind crossover; THC+CBD lower psychotomimetic scores than THC alone; CBD and placebo: no psychotomimetic effects
How They Did This
Naturalistic, randomized, double-blind, crossover, placebo-controlled study in 18 cannabis social club members. Tested four full-spectrum cannabis extracts: THC, CBD, THC+CBD, and placebo. Measured subjective and psychotomimetic effects.
Why This Research Matters
This is one of the first studies to show CBD's antipsychotomimetic effects using full-spectrum cannabis extracts in real-world settings rather than purified compounds in a laboratory. It provides ecological evidence for the protective role of CBD in cannabis products.
The Bigger Picture
As cannabis products become increasingly high-THC and low-CBD, this study reinforces the concern that removing CBD from cannabis (through selective breeding and concentration) eliminates a natural protective factor against psychotic-like effects. Products with balanced THC:CBD ratios may be inherently safer.
What This Study Doesn't Tell Us
Small sample (18 participants). Cannabis social club members are experienced users who may differ from the general population. Naturalistic setting introduced some variability. Self-reported subjective measures.
Questions This Raises
- ?What THC:CBD ratio provides optimal protection against psychotomimetic effects?
- ?Does chronic use with balanced THC:CBD products confer long-term psychiatric protection?
- ?Would CBD co-administration reduce psychosis risk in vulnerable populations?
Trust & Context
- Key Stat:
- CBD+THC: less psychotic effects than THC alone
- Evidence Grade:
- Double-blind crossover RCT with ecological validity, but small sample of experienced cannabis users.
- Study Age:
- Published in 2021; the THC:CBD ratio debate continues to inform product regulation.
- Original Title:
- Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
- Published In:
- Journal of clinical psychopharmacology, 41(5), 561-570 (2021)
- Authors:
- Sainz-Cort, Alberto(3), Jimenez-Garrido, Daniel(3), Muñoz-Marron, Elena(3), Viejo-Sobera, Raquel, Heeroma, Joost, Bouso, Jose Carlos
- Database ID:
- RTHC-03484
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does CBD make THC safer?
In this study, combining CBD with THC in a full-spectrum extract significantly reduced psychotic-like effects compared to THC alone. This supports the idea that CBD can counteract some of THC's problematic effects.
Does CBD alone cause any psychotic symptoms?
No. CBD alone produced scores identical to placebo, confirming it has no psychotomimetic properties on its own.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03484APA
Sainz-Cort, Alberto; Jimenez-Garrido, Daniel; Muñoz-Marron, Elena; Viejo-Sobera, Raquel; Heeroma, Joost; Bouso, Jose Carlos. (2021). Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.. Journal of clinical psychopharmacology, 41(5), 561-570. https://doi.org/10.1097/JCP.0000000000001457
MLA
Sainz-Cort, Alberto, et al. "Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.." Journal of clinical psychopharmacology, 2021. https://doi.org/10.1097/JCP.0000000000001457
RethinkTHC
RethinkTHC Research Database. "Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol ..." RTHC-03484. Retrieved from https://rethinkthc.com/research/sainz-cort-2021-opposite-roles-for-cannabidiol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.